ALYN Hospital Receives a $2.2M Grant

To Establish the First Research Center in Israel for Pediatric and Adolescent Rehabilitation

ALYN Hospital, Israel’s first and only pediatric and adolescent rehabilitation facility, has been awarded a donation of $2.189 million from The Leona M. and Harry B. Helmsley Charitable Trust, to establish the first center in Israel dedicated to groundbreaking research that will position Israel as a global leader in pediatric and adolescent rehabilitation development.

The Helmsley Charitable Trust is a global philanthropy committed to helping people live better lives today and creating stronger, healthier futures for individuals and communities. Since 2010, Helmsley has contributed over $434 million to Israel, including a donation of $12.5M last year to help fight the coronavirus pandemic.

ALYN Hospital’s new research center will focus on several relevant fields, including  cognitive, orthopedic and neurological rehabilitation, remote rehabilitation, mobility, and more. These are crucial areas to help ALYN’s young patients perform their daily activities and promote their integration into their communities. These patients are in need of rehabilitation due to various circumstances, such as accidents, diseases, birth defects, and developmental issues (such as cerebral palsy).  With the new research center, ALYN Hospital will be able to advance its treatment methods and approach. The research will be conducted in collaboration with other hospitals and organizations in Israel and around the world.

Arie Melamed, General Manager of ALYNnovation, the hospital’s innovation center, has been appointed as the Director of the Research Center, while Prof. Patrice L. (Tamar) Weiss, a world-renowned expert in the field of rehabilitation, will oversee the center’s scientific activities.

Sandor Frankel, a Helmsley Trustee, stated: “Helmsley is pleased to support ALYN Hospital, a distinguished institution qualified to lead the necessary research activities in the field of pediatric and adolescent rehabilitation in Israel, helping millions of young patients in the country and around the world who need innovative and groundbreaking treatments.”

“The new research center will allow us to expand our research and clinical trials, recruit additional professionals in the field, and continue to advance pediatric and adolescent rehabilitation in Israel and around the world,” says ALYN Hospital’s Director General Dr. Maurit Beeri. “The field of child rehabilitation has not received enough attention due to it being relatively limited,” explains Dr. Beeri. “By establishing this research center at the ALYN Hospital, in collaboration with our best researchers, doctors and senior therapists from various health fields, we will take a major step forward in the fields of research and development of technologies for the rehabilitation of children and adolescents.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Tabrecta is the first FDA-approved therapy to treat non small cell lung cancer with specific mutations (those that lead to mesenchymal-epithelial transition or MET exon 14 skipping).
The Cor® TRICUSPID ECM® valve has been successfully implanted in the 11th patient enrolled in the expansion by Dr. Marc Gerdisch, Chief of Cardiothoracic Surgery at Franciscan Health Heart Center in Indianapolis, Indiana & principal investigator for the adult component of the study.
Thirona notes LungQ 3.0.0 builds on 10 years of clinical trials and 200+ publications to deliver advanced segmentation of pulmonary segments and subsegments.
The Zeta Surgical Cranial Navigation System is a mixed-reality navigation system for neurosurgery, providing surgeons with "GPS-like" guidance with millimetric accuracy in real-time. Zeta's computer vision engine ensures maintained accuracy by automatically registering multiple times a second, accounting for patient movement, and allowing for awake and non-immobilized use in both operative and extra-operative settings.
The updated ZEISS femtosecond laser provides U.S. refractive surgeons with faster treatment, greater flexibility, and significant workflow enhancements.

By using this website you agree to accept Medical Device News Magazine Privacy Policy